Introduction
To control bleeding during surgery, conventional procedures such as ligation, direct compression, electrocauterization, and clipping are used. Topical hemostatic agents are available for treating oozing blood or bleeding from regions difficult to access by conventional methods. Uncontrolled surgical bleeding is associated with increased morbidity and mortality, higher hospital costs, and postoperative adhesions and infections. 1e3 Blood transfusions increase the risk of postoperative complications and have safety issues. Various hemostatic agents have been developed, 3e7 but improvement is needed in terms of efficacy, ease of handling, and safety, especially during laparoscopic surgery.
Among hemostatic materials, TachoSil (CSL Behring, King of Prussia, PA, USA) is a ready-to-use agent that comprises an equine collagen matrix coated with human fibrinogen and human thrombin. TachoSil is widely used in many surgical specialties and has proven to be a valuable tool for several indications. 6, 8, 9 TachoSil has shown clinical superiority in terms of hemostatic efficacy, duration of hospital stay, and postoperative utility for hepatic, cardiac, renal, lung, and pancreatic surgeries compared with conventional surgical procedures. 10e14 However, TachoSil has problems with intraoperative handling, especially at sites that are difficult to access, and is associated with higher risks of viral infection, other transferable diseases, and allergic reactions resulting from human hemostatic components. 2 To address the abovementioned problems, hemostatic agents that are safe and easy to handle and have sufficient hemostatic effects are needed. Gelatin-based hemostatic agents with or without fibrin components may be used during surgery 15e17 However, the hemostatic effects of gelatin matrix are controversial compared with other topical hemostatic agents 6 Gelatin-based agents without fibrin or thrombin components may be able to solve the problems mentioned above when usability is improved. In the present study, gelatin almost completely eliminated immunogenicity and viral activity by alkali treatment.
The remainder of this article describes the utility of a newly developed topical hemostatic agent, two-layer sheet of gelatin. TachoSil and the new product were compared in splenic injuries in which hemostasis is not easily achieved.
Materials and methods

Preparation of hemostatic agents
2.1.1. Two-layer sheet of gelatin Low endotoxin gelatin extracted from porcine skins (Type-I collagen, Medigelatin) with an isoelectric point of 5 was supplied by Nippi Co. Ltd. (Tokyo, Japan). The gelatin was dissolved in distilled water to concentrations of 1.0 wt% and 4.8 wt%. The gelatin 4.8 wt% solution was cast onto a polystyrene Petri dish (nontissue-culture treated; Corning Inc., Tokyo, Japan) and dried overnight on a clean bench at room temperature. The obtained film was slightly crosslinked by exposure to UV light for 2 minutes. The gelatin 1.0 wt% solution was cast onto a gelatin film on a Petri dish and placed in a deep freezer (MDF-U53V; SANYO Electric Co., Osaka, Japan) at À80 C for 30 minutes; it was then freeze dried for 24 hours in a vacuum freeze dryer (DRZ350WA; Advantec, Tokyo, Japan) in order to make a gelatin sponge. After freeze drying, a two-layered gelatin sheet composed of gelatin film and sponge layers was removed from the Petri dish and dehydrothermally cross-linked in a vacuum oven (DP41; Yamato Scientific Co. Ltd., Tokyo Japan) at 140 C for 3 hours. The two-layer sheet of gelatin was cut into square sheets of 30 mm Â 30 mm immediately before use (Figure 1 ).
TachoSil
TachoSil, which is composed of collagen matrix, fibrinogen, and thrombin was used in accordance with the manufacturer's instructions. TachoSil was cut into square sheets measuring 30 mm Â 30 mm immediately before use.
Gelatin sponge
A gelatin sponge was prepared using the same methods outlined above as a two-layer sheet of gelatin without undergoing the process to create a gelatin film (i.e., only a matrix made of sponge layer was used). After freeze drying, the gelatin sponge sheet was removed from the Petri dish and dehydrothermally cross-linked in a vacuum oven (DP41; Yamato Scientific Co. Ltd.) at 140 C for 3 hours. The gelatin sponge sheet was cut into square sheets measuring 30 mm Â 30 mm immediately before use.
Design of animal experiments
The animal experiments performed in this study were approved by the Doshisha University Animal Experimentation Committee. All animal care, housing, and surgical and anesthetic procedures were performed in accordance with Twenty-one nonpregnant, female, 2-year-old beagles weighing 9.5e10.5 kg were purchased from Shimizu Laboratory Animal Supply Co. Ltd. (Kyoto, Japan). During the experimental period, all dogs were housed separately and maintained under standard conditions (a lightedark cycle of 12:12 hours, mean temperature of 23 C, and mean humidity of 50%). Standard laboratory dog chow and water were freely available. Before the study, the dogs were housed in the laboratory for 1 week. On the 1 st day of the experiment, the health condition of all dogs was assessed.
Surgical procedure to evaluate the effects of hemostatic agents
All surgeries were performed under sterile conditions, by a team of three persons. The dogs were randomly assigned to one of three groups corresponding to each hemostatic material. Eighteen dogs were anesthetized with intravenous sodium pentobarbital (Somnopentyl Kyoritsu Seiyaku, Tokyo, Japan; 34 mg/kg). A 12-cm epigastric median incision was made. The surface of the upper or lower part of the spleen was reduced with scissors to 1e2 mm in depth and 20 mm Â 10 mm in area and allowed to bleed. Immediately after wiping blood from the spleen with gauze, one of three hemostatic materials (2-layer sheet of gelatin, TachoSil, gelatin sponge) was applied over the cut surface. Then, the hemostatic material was covered with gauze and digital pressure applied over it for 1 minute or 5 minutes; the gauze was removed gently so that immediate bleeding and rebleeding (bleeding after bleeding had stopped) could be observed during a 5-minute observation period. The physical status of the dogs remained stable during surgery. To exclude arbitrary procedure by operators or differences of conditions among experimental groups, the operators were blinded to the material being applied until astriction. Random study was scheduled for the experiments. This experiment was performed on six dogs for each hemostatic material. The time of rebleeding was recorded for each material.
Hemostatic effects were evaluated during an observation period of 5 minutes because the standard range in clinical tests using Duke's method is 1e5 minutes bleeding time. When blood was observed flowing out of the materials during the observation period, hemostasis was assessed as having been broken (rebleeding) and the time of rebleeding was recorded (Figure 2 ). The hemostatic materials were also evaluated for handling and ease of use during surgery.
Histological observation of implanted material and surrounding tissues
In order to observe histological change at the site of astriction, we examined three other dogs. The surfaces of the dogs' spleens were shaved to a size of 1 cm Â 1 cm under general anesthesia, and bleeding was confirmed; astriction was performed for 1 minute with gauze. One of the three hemostatic agents was then applied to the wound and pressed for >5 minutes with gauze over the material. After hemostasis was confirmed, the abdomen was closed. The whole spleens were excised 2 weeks after the initial operation under inhalation anesthesia. The parts of the spleen that had been covered with each hemostatic material were resected, fixed with formalin, and stained with hematoxylin and eosin. The tissue response to the materials and residues of the hemostatic materials were observed.
In vitro experiments for absorbency and permeability
The absorbency and permeability of each hemostatic material was evaluated using canine blood. Hemostatic materials were cut into 1 cm Â 1 cm squares. Single drops of 80 mL blood were placed by pipette on the hemostatic materials from a height of 1 cm. Absorption time was recorded as the time when the droplet disappeared from the material surface. Permeability was recorded as the time when the blood was exuded onto the material base.
Statistical analysis
The data are expressed as the mean AE standard deviation. Statistical analyses were carried out using the KruskaleWallis test and the chi-square test with Stat/Mate III, Windows (ATMS Co., Tokyo, Japan). A p value < 0.05 was considered statistically significant. Table 1 shows the results for the three groups of hemostatic agents. In the TachoSil group, hemostasis was not achieved in three of six spleens after a minute's duration of compression of the bleeding site. In all the other spleens applied with TachoSil, rebleeding was observed during the 5-minute observation period after decompression. With respect to the other two groups, initial hemostasis was achieved after a minute of astriction and rebleeding was not seen in any of the six spleens during the observation period. There were significant differences between the TachoSil group and the two other groups (p < 0.001).
Results
Hemostasis effects in animal experiments
In all groups, hemostasis was successfully achieved after 5 minutes of compression. In five of six spleens in the New hemostatic agent of gelatinTachoSil group, rebleeding within 5 minutes was observed. In gelatin sheet and gelatin sponge groups, there was no rebleeding observed throughout the observation period (Table 1) .
Absorbency and permeability of materials in vitro
The absorbency of the two-layer gelatin sheet (104 AE 115 seconds) and the gelatin sponge (277 AE 117 seconds) were significantly higher than that of TachoSil (>360 seconds; p < 0.05). Both the two-layer gelatin sheet and TachoSil had significantly (p < 0.05) low permeability (333 AE 61 seconds, > 360 seconds, respectively). The gelatin sponge had high permeability. That meant the two-layer sheet of gelatin had high absorbency and low permeability (Figure 3 ).
Usability of the materials during surgery
Blood from the spleen surface infiltrated the TachoSil and gelatin sponge and reached the compression gauze. The two kinds of gelatin preparations showed good adhesive properties because their sponge layer became an adherent gel after absorbing blood. By contrast, TachoSil was less adhesive after being soaked in blood and showed no gel formation. The gel layer, composed of gelatin sponge and blood, attached tightly to the compression gauze, but it became difficult to remove the gauze from the material surface in the gelatin sponge group. However, the gelatin "film" layer was impermeable, and the blood from the wound did not reach the compression gauze. It was easy to detach the gauze without removing the gelatin sheet from the wound (Figure 4 ).
Histological findings regarding embedded materials
There was strong invasion of inflammatory lymphocytes noted in the injured part of the spleen embedded with TachoSil. The collagen materials of TachoSil still remained for 2 weeks. In the gelatin groups, inflammatory change was absent ( Figure 5 ) and reepithelization was observed in 2 weeks. The gelatin materials were absorbed almost completely in 2 weeks. The wound healing in gelatin group was better than in TachoSil group.
Discussion
Our experiments showed that the two-layer sheet of gelatin has superiority over TachoSil in terms of hemostatic effects, utility, and safety in canine experiments.
Hemostatic effect
Topical hemostatic agents are used for the control of bleeding during surgery. Among the topical agents available, TachoSil has been shown to have superior hemostatic effects in various kinds of surgery.
9,11e14,18 By contrast, TachoSil was less effective in sites where a relatively large quantity of bleeding was seen because of weak adhesion to the bleeding site. 9 The hemostatic effect of gelatin matrix is still controversial, 3, 7, 15, 19, 20 but most of the studies we found showed that gelatin had a poor hemostatic effect compared with TachoSil. This prompted us to develop a two-layer sheet of gelatin to solve these problems.
The physical properties of gelatin matrix contribute to superior hemostatic effects compared with collagen matrix (TachoSil). In our study, the gelatin sponge layer smoothly and rapidly absorbed blood and activated autologous blood- coagulating components in blood (Figure 2 ). The sponge matrix changed to gel, which covered bleeding sites tightly. Moreover, the gelatin film layer of the two-layer gelatin sheet inhibited the permeation of blood, consequently strengthening adhesive bonding to the bleeding site. By contrast, the reduced permeability of the collagen sponge probably permitted continuous bleeding from the site, and subsequent bleeding or oozing disturbed the hemostatic effects of fibrinogen and thrombin because of the blood flowing out. The two-layer sheet of gelatin absorbed blood flowing into the material and coagulation occurred quickly, thereby allowing fibrin to bind the sheet and wound tightly. After hemostasis was completed, the hemostatic effects were not necessary. The thickness of the two-layer sheet of gelatin was thought to be enough to stop bleeding in this study. However, TachoSil absorbed flowing blood more slowly and coagulation inside TachoSil and on the surface of the material took longer to complete. Regarding the rebleeding, flexibility and adherence of the materials were thought to be more important than absorbency. The twolayer sheet of gelatin's ability to follow the shape of the wound surface is superior to that of TachoSil. The gelatin sheet can adhere to the tissue tightly after compression, but TachoSil leaves a small gap after astriction. Rebleeding can occur from a gap between the material and the wound.
In our study, we set the time for manual compression at 1 minute or 5 minutes to compare the different hemostatic materials. In past studies, compression time was set at longer than 3 minutes. Compared with the other materials, the initial hemostasis of TachoSil took longer and was incomplete, resulting in more frequent instances of rebleeding. The two-layer sheet of gelatin required a shorter time to complete hemostasis and the hemostatic effects were so secure that no rebleeding was found in any of the spleens tested. Overall, the hemostatic effect of the two-layer sheet of gelatin appears to be superior to TachoSil in sites where a relatively large quantity of bleeding is seen (e.g., spleen, pelvic floor, blood flow-rich parenchymal organs). 7, 21, 22 In the present study, we evaluated the hemostatic effects of three materials on a bleeding parenchymatous organ where bleeding is notoriously difficult to control. Conventional techniques for hemostasis and TachoSil are effective in cases where there is a small amount of bleeding and in sites where bleeding is easy to control. A two-layer sheet of gelatin is a possible choice for hemostasis in cases where there is a relatively large amount of bleeding.
Handling
The nonadhesive property of a gelatin "film" layer works more effectively to prevent bleeding immediately after the release of gauze compression. TachoSil and the gelatin sponge have a permeable layer and thus are disadvantageous for surgical handling because strong adhesion to compression gauze is more likely with the contact of blood and gauze, which may induce rebleeding after detachment. TachoSil is probably effective in cases where blood does not reach the compression gauze. The two-layer gelatin sheet and TachoSil present problems for laparoscopic surgery because they are both difficult to place into the abdominal cavity through a port. Gelatin materials must undergo refinements in order to be suitable for laparoscopic surgery. We are reforming gelatin materials for use during laparoscopic surgery.
Safety
Hemostatic agents remain in the body after surgery, therefore, long term safety is a very important issue. Excessive inflammatory response of the tissue by hemostatic materials can cause adhesion. Moreover, long term residues of the material possibly make the risk of infection higher. In the present study histological examination was carried out in order to observe the tissue response to the each material, not to examine the hemostatic effects of each material. Earlier regeneration of the peritoneum and earlier absorption of the material were observed in two-layer gelatin sheet. However, TachoSil induced intensive inflammatory response at the implanted site and remained longer than the gelatin sheet. Regarding adhesion, two-layer sheet of gelatin is possibly safer than TachoSil. 23e25 In our unpublished study (under submission) the two-layer gelatin sheet has an antiadhesive effect due to early regeneration of the peritoneum and mild inflammatory response.
The two-layer gelatin sheet, which is composed of alkaline-treated gelatin, does not carry the same risks as biomaterials (TachoSil), such as transmission of viral infection and allergic reactions. In fact, the gelatin alkalitreatment process eliminates the risk of transmittable diseases almost completely. 26 Moreover, from the skin of animals, infectivity of Bovine Spongiform Encephalopathy was not detected.
Conclusion
We showed that the two-layer gelatin sheet is a more effective, easier to handle, and safer topical hemostatic agent than TachoSil, which is one of the most popular materials currently in use. The two-layer sheet of gelatin is safer than topical agents including fibrin components and/ or thrombin in terms of risk of viral transmission and inflammatory reactions. We showed the hemostatic effectiveness of a two-layer sheet of gelatin in bleeding dog spleens (an organ where bleeding is difficult to control). The efficacy of newly developed materials should be evaluated by application to other organs (liver, kidney, lung, and vessels) and in humans.
